hyperthyroidism and glp-1 Medications & Thyroid Disease GLP1-RA and thyroid cancers –

Sjlund, K., Sandn, G., Hkanson, R

Efficacy and safety of once-weekly efpeglenatide monotherapy versus placebo in type 2 diabetes: the AMPLITUDE-M randomized controlled trial

Pancreatic safety of once-weekly dulaglutide in Chinese patients with type 2 diabetes mellitus: Subgroup analysis by potential influencing factors

Pro-inflammatory cytokines: The link between obesity and osteoarthritis

Decreased Appetite: Some individuals may experience a decrease in appetite while taking GLP-1 medications, which can be both a desired effect (supporting weight loss) and a potential side effect (leading to inadequate calorie intake)

When we are on a diet, reducing our caloric intake, or when we just don't have our regular appetite...or if semaglutide is making us nauseous...our protein intake suffers